Form Type: 4

SEC EDGAR Link
Accession Number:0001136261-22-000159
Date:2022-03-31
Issuer: SEELOS THERAPEUTICS, INC. (SEEL)
Original Submission Date:

Reporting Person:

MEHRA RAJ
C/O SEELOS THERAPEUTICS, INC.
300 PARK AVENUE, 2ND FLOOR NEW YORK, NY 10022

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-03-31 P 66,667 a $0.85 3,281,546 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the price reported in column 4 is a weighted average purchase price. these shares were acquired in multiple open market transactions at prices ranging from $0.8454 per share to $0.8600 per share, inclusive. the reporting person undertakes to provide to the staff of the securities and exchange commission, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares acquired at each separate price.

Elevate your investments